atHeart Medical gets FDA IDE approval for reSept ASD occluder’s second phase trial
Enrolling up to 250 patients, the prospective and single-arm study is designed to assess the safety and efficacy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Feb 22
Enrolling up to 250 patients, the prospective and single-arm study is designed to assess the safety and efficacy…
09 Feb 22
HeroTracker Sense is a next generation metered-dose inhaler (MDI) add-on connected device, which will help to address patient…
09 Feb 22
REVEALCovid-19 PLUS identifies the presence of total antibodies against SARS-CoV-2 generated by a previous infection or vaccination
09 Feb 22
RheOx is a new system that endoscopically delivers non-thermal pulsed electric field (PEF) energy to the lung airways…
09 Feb 22
Bioptx platform will integrate various sensing capabilities, including Rockley’s patented silicon-photonics-based laser technology
09 Feb 22
Cytovale is a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of…
08 Feb 22
The assay holds the capacity to precisely identify four viral infections, including Covid-19, respiratory syncytial virus (RSV), influenza…
08 Feb 22
Increased Sample Throughput and Consistency in COVID-19 and Other Swab-Based Tests is Supported through Use of the Novel…
08 Feb 22
The approximately 25,000-square-foot facility features expanded capabilities and new equipment for performing high-quality and efficient testing—creating more robust…
08 Feb 22
The company intends to use the funding to support a European feasibility study of its CroíValve Transcatheter Tricuspid…